The Anti-Inflammatory Therapeutics Market can be segmented based on drug class into Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs, and Corticosteroids.
Under the drug class segment, Anti-inflammatory Biologics are expected to witness significant growth due to their targeted approach in treating inflammatory diseases such as arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel disease, and other inflammatory diseases.
Indication:
In terms of indication, the Anti-Inflammatory Therapeutics Market can be categorized into arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel disease, and other inflammatory diseases. Arthritis is anticipated to dominate the market owing to the rising prevalence of the disease globally.
Application:
The market can also be segmented based on application into autoimmune, inflammatory diseases, and respiratory diseases. With the increasing prevalence of autoimmune diseases, the autoimmune segment is expected to witness substantial growth in the Anti-Inflammatory Therapeutics Market.
Distribution Channel:
On the basis of distribution channel, the Anti-Inflammatory Therapeutics Market can be divided into hospital pharmacy and retail pharmacy. The hospital pharmacy segment is projected to hold a significant share in the market due to the availability of a wide range of anti-inflammatory therapeutics in hospitals for the treatment of various inflammatory diseases.